Marchal G, Beaudouin V, Rioux P, de la Sayette V, Le Doze F, Viader F, Derlon J M, Baron J C
INSERM U320, Centre Cyceron, Caen, France.
Stroke. 1996 Apr;27(4):599-606. doi: 10.1161/01.str.27.4.599.
The existence in humans of brain tissue at risk for infarction but potentially viable (eg, the penumbra) remains unproven. One retrospective operational definition of such tissue includes its final infarction despite a relatively preserved or even normal cerebral metabolic rate of oxygen (CMRO2) in the early hours after stroke onset. Although previous positron emission tomography (PET) studies identified tissue whose CMRO2 declined from the acute to the subacute stage, in principle compatible with deteriorating penumbra, they all lacked a coregistered CT scan mapping of final infarct and an objective three-dimensional PET data analysis, while many patients were studied in the subacute (up to 48 hours) phase. We have evaluated whether tissue with CMRO2 ranging above a threshold for presumably irreversible damage in the first 18 hours of middle cerebral artery territory stroke, but below it in the chronic stage, could be retrospectively identified within the final infarct volume.
Our data bank comprises 30 consecutive patients with first-ever middle cerebral artery territory stroke prospectively studied with PET within the first 18 hours after clinical onset; the 15O equilibrium method was used to measure cerebral blood flow and CMRO2. All survivors with the following criteria were eligible for the present study: (1) technically adequate chronic-stage PET performed in the same stereotaxic conditions, (2) coregistered CT scan also performed in the chronic stage, and (3) an infarct of sufficient dimension (>16mm diameter) on late CT. Corresponding CT scan cuts and PET slices were exactly realigned, and the outlines of CT hypodensities were superimposed on the corresponding CMRO2 matrix. Infarcted voxels with CMRO2 values less than or greater than 1.40 mL/100 mL per minute (ie, the generally accepted threshold for irreversible damage) were automatically identified and projected on matrices of all other PET parameters and for both PET studies.
Eight patients (mean age, 78 Years) were eligible for the present study. The acute-stage PET study was performed 7 to 17 hours after stroke onset and the chronic-stage PET 13 to 41 days later. Within the final infarct, mean CMRO2 fell significantly from the acute- to the chronic-stage PET study (P<.001). Eventually infarcted voxels with acute-stage CMRO2 values above the threshold were found in each of these eight patients; they were most often situated near the infarct borders and constituted 10% to 52% (mean, 32%) of the final infarct volume. The acute-stage CMRO2 in these voxels ranged up to 4.13 mL/100 mL per minute but fell below 1.40 mL/100 mL per minute in 93% of them at the chronic-stage PET. in 7 of 8 patients the acute-stage mean cerebral blood flow ranged from 10 to 22 mL/100 mL per minute, and the mean oxygen extraction fraction was markedly increased (>0.70) in these voxels, consistent with a penumbral state.
In a strictly homogeneous sample of prospectively studied patients, we have identified, up to 17 hours after stroke onset, substantial volumes of tissue with CMRO2 well above the assumed threshold for viability that nevertheless spontaneously evolved toward necrosis. This tissue exhibited penumbral ranges of both cerebral blood flow and oxygen extraction fraction and thus could represent the part of penumbra that might be saved with appropriate therapy.
人类大脑中存在有梗死风险但可能存活的组织(如半暗带)这一情况仍未得到证实。对此类组织的一种回顾性操作定义包括,尽管在卒中发作后的最初数小时内脑氧代谢率(CMRO2)相对保持甚至正常,但该组织最终仍发生梗死。尽管先前的正电子发射断层扫描(PET)研究确定了CMRO2从急性期到亚急性期下降的组织,原则上与逐渐恶化的半暗带相符,但这些研究都缺乏最终梗死灶的配准CT扫描图以及客观的三维PET数据分析,而且许多患者是在亚急性期(长达48小时)进行研究的。我们评估了在大脑中动脉区域卒中的最初18小时内CMRO2高于推测不可逆损伤阈值但在慢性期低于该阈值的组织,是否能在最终梗死体积内被回顾性识别。
我们的数据库包含30例首次发生大脑中动脉区域卒中的连续患者,在临床发作后的最初18小时内进行了PET前瞻性研究;采用15O平衡法测量脑血流量和CMRO2。所有符合以下标准的幸存者均符合本研究条件:(1)在相同立体定向条件下进行技术上足够的慢性期PET检查,(2)在慢性期也进行了配准CT扫描,(3)晚期CT上有足够大小(直径>16mm)的梗死灶。将相应的CT扫描切面和PET切片精确重新对齐,并将CT低密度区的轮廓叠加在相应的CMRO2矩阵上。自动识别CMRO2值小于或大于每分钟1.40 mL/100 mL(即公认的不可逆损伤阈值)的梗死体素,并投影到所有其他PET参数的矩阵以及两项PET研究中。
8例患者(平均年龄78岁)符合本研究条件。急性期PET研究在卒中发作后7至17小时进行,慢性期PET在13至第41天进行。在最终梗死灶内,从急性期PET研究到慢性期PET研究,平均CMRO2显著下降(P<0.001)。在这8例患者中,每例均发现急性期CMRO2值高于阈值的最终梗死体素;它们最常位于梗死灶边界附近,占最终梗死体积的10%至52%(平均32%)。这些体素中的急性期CMRO2高达每分钟4.13 mL/100 mL,但在慢性期PET时,其中93%的体素下降至低于每分钟1.40 mL/100 mL。在8例患者中的7例中,急性期平均脑血流量为每分钟10至22 mL/100 mL,这些体素中的平均氧摄取分数显著升高(>0.70),符合半暗带状态。
在一个经过前瞻性研究的严格同质样本中,我们发现在卒中发作后长达17小时内,大量CMRO2远高于假定存活阈值的组织却自发演变为坏死。该组织表现出脑血流量和氧摄取分数的半暗带范围,因此可能代表了通过适当治疗可能挽救的半暗带部分。